James Miskin

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

Stéphane Palfi, Jean Marc Gurruchaga, G. Ralph et al. · The Lancet · 2014 · 436 citations

Medicine, Neuroscience, Pharmacology +16

African Swine Fever Virus Protein p54 Interacts with the Microtubular Motor Complex through Direct Binding to Light-Chain Dynein

Covadonga Alonso, James Miskin, Bruno Hernáez et al. · Journal of Virology · 2001 · 199 citations

Life Sciences, Infectious Diseases, Molecular Biology +17

Dopamine Gene Therapy for Parkinson’s Disease in a Nonhuman Primate Without Associated Dyskinesia

Béchir Jarraya, Sabrina Boulet, G. Ralph et al. · Science Translational Medicine · 2009 · 178 citations · Full text

Medicine, Neurology, Neuroscience +17

A Viral Mechanism for Inhibition of the Cellular Phosphatase Calcineurin

James Miskin, Charles C. Abrams, Lynnette C. Goatley et al. · Science · 1998 · 139 citations

Life Sciences, Immunology, Molecular Biology +17

Transduction of Photoreceptors With Equine Infectious Anemia Virus Lentiviral Vectors: Safety and Biodistribution of StarGen for Stargardt Disease

Katie Binley, Peter Widdowson, Julie Loader et al. · Investigative Ophthalmology & Visual Science · 2013 · 110 citations · Full text

Pharmacy, Ophthalmology, Pharmaceutics +17